Data / Form D filings / Plasmonix, Inc.
Plasmonix, Inc.: Form D filings
Plasmonix, Inc., a biotechnology company in Gaithersburg, MD, filed 6 Form D notices with the SEC between 2011 and 2015. The latest, on July 7, 2015, reports $543,857 sold of a $564,942 offering to 11 investors.
Find out what Plasmonix, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9119 GAITHER ROAD, Gaithersburg, MD, 20877
- Phone
- (410) 625-5939
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Maryland
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1521534
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7, 2015 | Amendment | $564,942 | $543,857 | $21,085 | 11 | Jun 13, 2014 | sec.gov |
| Jun 13, 2014 | New notice | $564,942 | $314,942 | $250,000 | 10 | Jun 13, 2014 | sec.gov |
| Nov 13, 2013 | New notice | $500,000 | $231,069 | $268,931 | 7 | Nov 6, 2013 | sec.gov |
| Jul 3, 2013 | New notice | $550,000 | $300,000 | $250,000 | 1 | Apr 15, 2013 | sec.gov |
| Jun 7, 2012 | New notice | $500,000 | $298,264 | $201,736 | 15 | May 24, 2012 | sec.gov |
| Jun 21, 2011 | New notice | $2,000,000 | $1,217,417 | $782,583 | 18 | Jun 17, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven W. Meltzer | Director | |
| Edward M. Rudnic, PhD | Director | |
| Jesse Baumgold, PhD | Executive Officer, Director | |
| John W. Holaday | Executive Officer, Director | |
| David W. Manyak | Director |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Jul 6, 2015 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Plasmonix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.